CX-516
CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and had been undergoing development by a collaboration between Cortex, Shire, and Servier. It was studied as a potential treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD.
primaryTopic
CX-516
CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and had been undergoing development by a collaboration between Cortex, Shire, and Servier. It was studied as a potential treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD.
has abstract
CX-516 es un fármaco ampakina ...... ase, tales como el y CX-717.
@es
CX-516 is an ampakine and noot ...... or and CX-717 are compared to.
@en
CAS number
154235-83-3
ChEMBL
FDA UNII code
Z5QU38B4V9
KEGG
PubChem
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
970,044,270
Link from a Wikipage to another Wikipage
CAS number
ChEMBL
ChemSpiderID
elimination half-life
IUPAC name
IUPHAR ligand
PubChem
SMILES
O=CN3CCCCC3
@en
StdInChIKey
ANDGGVOPIJEHOF-UHFFFAOYSA-N
@en
UNII
Z5QU38B4V9
@en
verifiedrevid
443,492,828
Watchedfields
changed
@en
wikiPageUsesTemplate
subject
hypernym
comment
CX-516 es un fármaco ampakina ...... omo tratamiento para el ADHD.
@es
CX-516 is an ampakine and noot ...... mined as a treatment for ADHD.
@en
label
CX-516
@en
CX-516
@es